Abingdon Health (LON:ABDX) Stock Price Up 6% – Still a Buy?

Abingdon Health Plc (LON:ABDX)’s stock price was up 6% during mid-day trading on Wednesday . The stock traded as high as GBX 8.75 ($0.11) and last traded at GBX 8.75 ($0.11). Approximately 15,850 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 223,908 shares. The stock had previously closed at GBX 8.25 ($0.11).

Abingdon Health Stock Performance

The firm has a market capitalization of £15.64 million, a P/E ratio of -899.00 and a beta of 0.13. The company has a current ratio of 1.95, a quick ratio of 1.96 and a debt-to-equity ratio of 46.64. The stock has a 50 day simple moving average of GBX 9.40 and a 200-day simple moving average of GBX 10.13.

About Abingdon Health

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.